NCT07428291 Early Rehabilitationin in Tibial Spine Avulsion Fracture Managed With Arthoscopic Fibre Wire Fixation
| NCT ID | NCT07428291 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abdul Jabbar |
| Condition | Avulsion Fracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-02-27 |
| Primary Completion | 2026-05-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-02-27 with a primary completion date of 2026-05-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Tibial spine avulsion fracture is a common knee injury in adolescents and young adults, often caused by sports trauma or falls. It involves avulsion of the anterior cruciate ligament (ACL) attachment from the tibial eminence and may lead to pain, restricted range of motion, instability, and long-term functional limitations. Arthroscopic fixation using fiber wire is a widely accepted surgical technique for restoring joint stability. However, there is ongoing debate regarding the optimal timing of postoperative rehabilitation. Traditionally, delayed rehabilitation protocols have been used to protect the surgical repair, but prolonged immobilization may lead to joint stiffness, quadriceps atrophy, delayed recovery, and prolonged return to sports. Early rehabilitation protocols aim to initiate controlled mobilization soon after surgery to enhance recovery of knee range of motion, muscle strength, and functional performance while maintaining surgical stability. This randomized clinical trial will compare the effectiveness of early rehabilitation versus conventional (delayed) rehabilitation in patients aged 15-25 years who undergo arthroscopic fiber wire fixation for tibial spine avulsion fracture. Outcomes including knee range of motion (measured using a goniometer), muscle strength (measured using a hand-held dynamometer), and functional disability (assessed using the International Knee Documentation Committee (IKDC) Score) will be evaluated at baseline, 6 weeks, and 12 weeks postoperatively. The findings of this study may help establish evidence-based rehabilitation guidelines and determine whether early rehabilitation provides superior functional outcomes compared to conventional therapy following tibial spine fixation.
Eligibility Criteria
Inclusion Criteria: * Both Gender * Age 15-25 Years * General Population * History of Fall, * Sports Activity Exclusion Criteria: * Neglected Tibial Spine Avulsion Fracture for more than 6 months. * Polytrauma, e.g., femur fracture, tibial fracture (other than tibial spine or condylar fracture), patella fracture. * Multiligamentous Knee Injury, e.g., PCL injury, PLC, LCL, MCL, patellofemoral ligament (MPFL) injury, meniscus injury. * Other Deformative Problems, Genu Valgus, Genu Varus
Contact & Investigator
Abdul Jabbar, MSPTS
PRINCIPAL INVESTIGATOR
The University of Lahore, Lahore
Frequently Asked Questions
Who can join the NCT07428291 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 25 Years, studying Avulsion Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07428291 currently recruiting?
Yes, NCT07428291 is actively recruiting participants. Contact the research team at 70176356@student.uol.edu.pk for enrollment information.
Where is the NCT07428291 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07428291 clinical trial?
NCT07428291 is sponsored by Abdul Jabbar. The principal investigator is Abdul Jabbar, MSPTS at The University of Lahore, Lahore. The trial plans to enroll 56 participants.